FDA authorized the Pfizer-BioNTech COVID booster for children aged 5 to 11 five months after they have finished the first two-shot vaccination series.
USA TODAY, USA Today
Tue, 05/17/2022 - 9:01am
FDA authorized the Pfizer-BioNTech COVID booster for children aged 5 to 11 five months after they have finished the first two-shot vaccination series.